HGG-25. TARGETING THE EPIGENETIC MODIFIER HMGA2 IN DIPG AND HIGH GRADE GLIOMAS INHIBITS PROLIFERATION, INVASION AND TUMORIGENICITYHarpreet Kaur, Eric H. Raabe, Charles G. Eberhart et al.|Neuro-Oncology|2019Cited by 1
Abstract 2888: Targeting the fatal pediatric brain tumors AT/RT and DIPG with the DNA binding agent quinacrineHarpreet Kaur, Eric H. Raabe, Charles G. Eberhart et al.|Tumor Biology|2019Cited by 1
ATRT-05. REPURPOSED ANTI-MALARIAL QUINACRINE ACTIVATES P53 AND INHIBITS ATRT TUMORIGENICITYHarpreet Kaur, Eric H. Raabe, Akhila Parthasarathy et al.|Neuro-Oncology|2021Cited by 1
Abstract 4850: The minor groove binding agent quinacrine inhibits growth and increases apoptotic death in diffuse intrinsic pontine glioma tumor cellsHuizi Guo, Eric H. Raabe, Charles G. Eberhart et al.|Cancer Research|2018Cited by 0
Abstract 3449: A novel rapid zebrafish model for validation of potential therapies for fatal pediatric brain tumorsHarpreet Kaur, Eric H. Raabe, Jeff S. Mumm et al.|Cancer Research|2020Cited by 0